title: Br Ca Pt sample #E4751072-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92091_H133A2_E4751072_1


title: Br Ca Pt sample #E4751070-1

status: Public on Jan 01 2013

type: RNA

city: Princeton

first: Christine

last: Horak

state: NJ

address: Route 206 and Province Line Road

country: USA

institute: Bristol-Myers Squibb

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92087_H133A2_E4751070_1

hyb_protocol: Labeled cRNA targets with greater than or equal to 10 micrograms yield were hybridized Affymetrix Human Genome (HG) U133A 2.0 GeneChips

scan_protocol: Affymetrix GeneChip Scanner 3000

data_processing: RMA background correction and normalization using R (v.2.8.1) and affy package (v.1.20.2)

label: biotin

molecule: total RNA

organism: Homo sapiens

label_protocol: Biotinylated cRNA were prepared according to the Affymetrix in vitro transcription (IVT) labeling kit

extract_protocol: Total RNA was extracted from RNAlater samples using standard procedures.

tag: specimen name

tag: gender

value: female

tag: age

tag: treatment arm

value: Ixabepilone

tag: ac response

value: stable disease

tag: basetms

value: > 5 cm

tag: er

value: positive

tag: pr

value: negative

value: other

tag: mnssl

value: pre-menopausal

tag: pcr

value: No


title: Br Ca Pt sample #A7573397-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92067_H133A2_A7573397_1


title: Br Ca Pt sample #E4534819-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92070_H133A2_E4534819_1

value: partial response

value: < 2 cm

value: Yes


title: Br Ca Pt sample #A6736485-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83644_H133A2_A6736485_1

value: complete response

value: not reported


title: Br Ca Pt sample #L0628963-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92060_H133A2_L0628963_1

value: post-menopausal


title: Br Ca Pt sample #E4690595-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92098_H133A2_E4690595_1


title: Br Ca Pt sample #E4710305-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87668_H133A2_E4710305_1


title: Br Ca Pt sample #E4708763-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92095_H133A2_E4708763_1


title: Br Ca Pt sample #S1032221-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87458_H133A2_S1032221_1


title: Br Ca Pt sample #S1076366-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87451_H133A2_S1076366_1


title: Br Ca Pt sample #A7330542-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87407_H133A2_A7330542_1


title: Br Ca Pt sample #A7082102-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87422_H133A2_A7082102_1


title: Br Ca Pt sample #E4477306-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87639_H133A2_E4477306_1

value: peri-menopausal


title: Br Ca Pt sample #A6952000-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83642_H133A2_A6952000_1


title: Br Ca Pt sample #E4340700-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87630_H133A2_E4340700_1


title: Br Ca Pt sample #S1123419-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87444_H133A2_S1123419_1


title: Br Ca Pt sample #E4343479-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81471_H133A2_E4343479_1


title: Br Ca Pt sample #E4222992-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87618_H133A2_E4222992_1


title: Br Ca Pt sample #E4606438-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87644_H133A2_E4606438_1


title: Br Ca Pt sample #A7295220-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83653_H133A2_A7295220_1


title: Br Ca Pt sample #E3800101-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87647_H133A2_E3800101_1


title: Br Ca Pt sample #S1126096-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87441_H133A2_S1126096_1


title: Br Ca Pt sample #E4332196-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83720_H133A2_E4332196_1


title: Br Ca Pt sample #A7241236-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87400_H133A2_A7241236_1


title: Br Ca Pt sample #E3916680-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81483_H133A2_E3916680_1


title: Br Ca Pt sample #E4343481-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87636_H133A2_E4343481_1


title: Br Ca Pt sample #A7082100-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87420_H133A2_A7082100_1


title: Br Ca Pt sample #S1032225-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80471_H133A2_S1032225_1


title: Br Ca Pt sample #E4606440-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87645_H133A2_E4606440_1


title: Br Ca Pt sample #S1032217-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56182_H133A2_S1032217_1


title: Br Ca Pt sample #S1089746-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80473_H133A2_S1089746_1


title: Br Ca Pt sample #E4639353-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87638_H133A2_E4639353_1


title: Br Ca Pt sample #E4340702-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87646_H133A2_E4340702_1


title: Br Ca Pt sample #S1297269-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87465_H133A2_S1297269_1


title: Br Ca Pt sample #A6997531-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87418_H133A2_A6997531_1


title: Br Ca Pt sample #S1116462-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80468_H133A2_S1116462_1


title: Br Ca Pt sample #A6999197-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87417_H133A2_A6999197_1


title: Br Ca Pt sample #S1038589-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56175_H133A2_S1038589_1

value: progressive disease


title: Br Ca Pt sample #E3800109-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56190_H133A2_E3800109_1

value: female


title: Br Ca Pt sample #A6263065-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53532_H133A2_A6263065_1


title: Br Ca Pt sample #A6263061-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53531_H133A2_A6263061_1


title: Br Ca Pt sample #E3837722-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56188_H133A2_E3837722_1


title: Breast tumor biopsy_Postchemotherapy_08SE143

status: Public on Dec 12 2012

city: Jaen

first: Laura

last: Vera

state: Jaen

address: Avenida del Ejercito Español 10

department: Department of Oncology

country: Spain

institute: Hospital Medico-Quirurgico de Jaen

description: Affymetrix Standard Protocol

hyb_protocol: Affymetrix GeneChip Hybridization Standard Protocol

scan_protocol: Affymetrix GeneChip Scan Standard Protocol

data_processing: Data were pre-processed by RMA method, filtered and normalized using Partek Genomics Suite v7.3.1 (Partek). Data were filtered again and a lineal regression model was applied to detect significant differences in gene expression between groups. Expression ratios of the differentially expressed genes are presented as fold changes.

source_name: Breast tumor biopsy, Postchemotherapy

label_protocol: Affymetrix's GeneChip IVT Labelling Kit (Affymetrix)

extract_protocol: Total RNA was extracted using using an RNeasy minikit from Qiagen. Quality and quantity was assessed by agarose electrophoresis and spectrophotometric analysis (Absorbance 260/280 nm)

treatment_protocol: RNA processing: snap frozen in liquid nitrogen and preserved at -80ºC. Before RNA extraction protocol, samples were sectioned in a cryostat to evalute the celularity.

tag: tissue

value: breast tumor

tag: tumor biopsy acquisition

value: Such biopsy was taken from surgery specimen and selected by the pathologist in charge within 30 min. after tumor removal

tag: treatment

value: A

tag: pathologic response to chemotherapy (miller & payne grade)


title: Breast tumor biopsy_Postchemotherapy_08SE161

description: Affymetrix Standard Protocol


title: Br Ca Pt sample #S1178752-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87464_H133A2_S1178752_1

data_processing: RMA background correction and normalization using R (v.2.8.1) and affy package (v.1.20.2).

value: positive


title: Breast tumor biopsy_Postchemotherapy_08SE185

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE169

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE147

description: Affymetrix Standard Protocol

value: B


title: Breast tumor biopsy_Postchemotherapy_08SE183

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE155

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE1175

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE163

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE274

description: Affymetrix Standard Protocol

value: C


title: Breast tumor biopsy_Postchemotherapy_08SE165

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE167

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE273

description: Affymetrix Standard Protocol

source_name: Breast tumor biopsy, Prechemotherapy

tag: trucut biopsy

value: Such biopsy was taken at diagnosis

value: none(Prechemotherapy)


title: Breast tumor biopsy_Prechemotherapy_08SE182

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE166

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE174

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE139

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE160

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE162

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE168

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE154

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE164

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE146

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE136

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE279+08SE280

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE142

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE157

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE138

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE137

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE181

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE190

description: Affymetrix Standard Protocol

value: none (Prechemotherapy)


title: Breast tumor biopsy_Prechemotherapy_08SE186

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE177

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE156

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE132

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE153

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE176

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE133

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE141

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE144

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE129

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE130

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE159

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE278

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE171

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE179

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE276+08SE277

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE189

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Postchemotherapy_08SE135

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE188

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE172

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE275

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE140

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE180

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE158

description: Affymetrix Standard Protocol


title: Breast tumor biopsy_Prechemotherapy_08SE152

description: Affymetrix Standard Protocol


title: breast cancer US179

status: Public on Dec 11 2012

city: Houston

first: Yuan

last: Qi

state: TX

address: 1400 Pressler St

department: Bioinformatics & Computational Biology

institute: University of Texas M.D. Anderson Cancer Center

description: Gene expression data from breast cancer FNA biopsy, pre-treatment

hyb_protocol: Following fragmentation, 20 ug of cRNA were hybridized to affymetrix U133A arrays overnight at 42C. Microarrays were washed and stained in the Affymetrix Fluidics Station.

scan_protocol: GeneChips were scanned using the Affymetrix GeneChip Scanner 3000DX. This system is manufactured by Affymetrix Inc in Santa Clara, CA.

data_processing: The RMAExpress V1.05 software package (http://rmaexpress.bmbolstad.com) was used to generate probe level intensities by setting the operating parameters as: Background adjust: Yes; Normalization: Quantile; Summarization method: Probe level model. The probe level intensities were log2- transformed before further analyses. Non-specific filtering was applied to remove probe sets having small variation (interquartile range < 0.5) or low expression values (median < log2(100)) across all samples. The expression values were then standardized to mean zero and standard deviation one for each sample.

source_name: breast cancer FNA biopsy, pre-treatment

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from at least 1 ug total RNA using the BioArray High Yield RNA transcript labeling kit (Enzo Laboratories).

extract_protocol: total RNA was extracted from the FNA specimens using Qiagen RNeasy kit following the manufacturer’s instructions (http://www.qiagen.com).

tag: pcr (1) vs rd (0)

tag: tx.score (lower score, greater chemo sensitive)

tag: tfec.score (lower score, greater chemo sensitive)

tag: mammaprint.score (lower score, greater chemo sensitive)

tag: ror.s.score (higher score, greater chemo sensitive)

tag: ror.p.score (higher score, greater chemo sensitive)

tag: prechemo t

tag: prechemo n

tag: prechemo n.status (1

value: positive, 0:negative):NA

tag: er.status (1

value: positive, 0:negative):1

tag: pr.status (1

tag: her2.status (1

value: FEC/TX+H


title: breast cancer US177

tag: fec.score (lower score, greater chemo sensitive)

tag: age


title: breast cancer US186


title: breast cancer US184

value: positive, 0:negative):0


title: breast cancer US180


title: breast cancer US181


title: Breast tumor biopsy_Prechemotherapy_08SE128

description: Affymetrix Standard Protocol

treatment_protocol: RNA processing: snap frozen in liquid nitrogen and preserved at -80ºC. Before RNA extraction protocol, samples were sectioned in a cryostat to evalute the celularity

tag: gender

tag: tissue

tag: tumor biopsy acquisition

tag: treatment


title: Breast tumor biopsy_Prechemotherapy_08SE134

description: Affymetrix Standard Protocol

tag: trucut biopsy

tag: pathologic response to chemotherapy (miller & payne grade)


title: breast cancer US190

tag: pcr (1) vs rd (0)

tag: tx.score (lower score, greater chemo sensitive)

tag: tfec.score (lower score, greater chemo sensitive)

tag: mammaprint.score (lower score, greater chemo sensitive)


title: Breast tumor biopsy_Prechemotherapy_08SE170

description: Affymetrix Standard Protocol


title: breast cancer US168

tag: ror.s.score (higher score, greater chemo sensitive)

tag: ror.p.score (higher score, greater chemo sensitive)

tag: prechemo t

tag: prechemo n


title: breast cancer US173

tag: prechemo n.status (1

tag: er.status (1

tag: pr.status (1

tag: her2.status (1


title: breast cancer US163

tag: fec.score (lower score, greater chemo sensitive)

tag: age


title: Breast tumor biopsy_Prechemotherapy_08SE178

description: Affymetrix Standard Protocol

tag: gender

tag: tissue

tag: tumor biopsy acquisition

tag: treatment


title: breast cancer US169

tag: pcr (1) vs rd (0)

tag: tx.score (lower score, greater chemo sensitive)


title: breast cancer US170

tag: tfec.score (lower score, greater chemo sensitive)

tag: mammaprint.score (lower score, greater chemo sensitive)


title: breast cancer US145

tag: ror.s.score (higher score, greater chemo sensitive)

tag: ror.p.score (higher score, greater chemo sensitive)


title: breast cancer US164

tag: prechemo t

tag: prechemo n


title: breast cancer US142

tag: prechemo n.status (1

tag: er.status (1


title: breast cancer US172

tag: pr.status (1

tag: her2.status (1


title: breast cancer US144

tag: fec.score (lower score, greater chemo sensitive)

tag: age


title: breast cancer US148


title: breast cancer US149


title: breast cancer US137


title: breast cancer US134


title: breast cancer US127


title: breast cancer US135

value: FEC/TX


title: breast cancer US102


title: breast cancer US112


title: breast cancer US131


title: breast cancer US166


title: breast cancer US118


title: breast cancer US111


title: breast cancer US165


title: breast cancer US085


title: breast cancer US160


title: breast cancer US182


title: breast cancer US128


title: breast cancer US110


title: breast cancer US154


title: breast cancer US158


title: breast cancer US143


title: breast cancer US132


title: breast cancer US141


title: breast cancer US104


title: breast cancer US108


title: breast cancer US122


title: breast cancer US117


title: breast cancer US116


title: breast cancer US101


title: breast cancer US151


title: breast cancer US099


title: breast cancer US095


title: breast cancer US090


title: breast cancer US107


title: breast cancer US103


title: breast cancer US096


title: breast cancer US067


title: breast cancer US100


title: breast cancer US072


title: breast cancer US074


title: breast cancer US089


title: breast cancer US093


title: breast cancer US057


title: breast cancer US054


title: breast cancer US088


title: breast cancer US084


title: breast cancer US051


title: breast cancer US087


title: breast cancer US047


title: breast cancer US082


title: breast cancer US060


title: breast cancer US059


title: breast cancer US080


title: Breast tumor biopsy_Postchemotherapy_08SE173

description: Affymetrix Standard Protocol

tag: gender

tag: tissue

tag: pathologic response to chemotherapy (miller & payne grade)


title: breast cancer US033

tag: pcr (1) vs rd (0)


title: breast cancer US032

tag: tx.score (lower score, greater chemo sensitive)


title: breast cancer US049

tag: tfec.score (lower score, greater chemo sensitive)


title: breast cancer US019

tag: mammaprint.score (lower score, greater chemo sensitive)


title: breast cancer US011

tag: ror.s.score (higher score, greater chemo sensitive)


title: breast cancer US014

tag: ror.p.score (higher score, greater chemo sensitive)


title: breast cancer US005

tag: prechemo t


title: breast cancer US071

tag: prechemo n


title: breast cancer US038

tag: prechemo n.status (1


title: breast cancer US020

tag: er.status (1


title: breast cancer US034

tag: pr.status (1


title: breast cancer US037

tag: her2.status (1


title: breast cancer US026

tag: fec.score (lower score, greater chemo sensitive)


title: breast cancer US016

tag: age


title: breast cancer US023


title: breast cancer US024


title: breast cancer US022


title: breast cancer US055


title: Breast cancer tumor OU-111

status: Public on Mar 20 2012

city: Suita

first: Shinzaburo

last: Noguchi

state: Osaka

address: 2-2-E10 Yamada-oka

department: Breast and Endocrine Surgery

country: Japan

institute: Osaka University, Graduate School of Medicine

hyb_protocol: Following fragmentation, 5 ug of cRNA were hybridized overnight at 46C on Affymetrix U133 plus2.0 arrays. GeneChips were washed and stained in the Affymetrix GeneChip Fluidics Station 450.

scan_protocol: GeneChips were scanned using the diagnostic-grade Affymetrix scanner 3000.

data_processing: Probe intensities were quantified with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings.

source_name: breast cancer

label_protocol: RNA (50 ng) was subjected to the generation of second-strand combinational DNA (cDNA), and cRNA was amplified with a random primer (WT-Ovation FFPE RNA Amplification System V2; NuGEN, Cincinnati, Ohio). Next, the amplified cRNA was biotinylated and fragmented with the FL-Ovation cDNA Biotin Module V2 (NuGEN).

extract_protocol: Trizol (Invitrogen, Carlsbad, Calif) was used to extract RNA from core-needle tumor biopsy samples that were obtained with the Mammotome.

treatment_protocol: Patients prospectively consented to a research biopsy by vacuum-assisted core-biopsy instrument (Mammotome 8G; HH Ethicon Endosurgery, Johnson and Johnson Company) under ultrasonographic guidance for histologic examination and gene expression analysis prior to any systemic therapy, and to the future assessment of pathologic response

value: breast cancer tumor

tag: clinical t stage

tag: lymph node status

tag: clinical stage

value: IIB

tag: histological grade

tag: er status ihc

value: negative

tag: pr status ihc

tag: her2 status fish

tag: pathologic response pcr ncr

value: pCR


title: Breast cancer tumor OU-115

tag: tissue

value: IIA


title: Breast cancer tumor OU-108

value: nCR


title: Breast cancer tumor OU-113

value: positive


title: Breast cancer tumor OU-105


title: Breast cancer tumor OU-100


title: Breast cancer tumor OU-112


title: Breast cancer tumor OU-98


title: Breast cancer tumor OU-107


title: Breast cancer tumor OU-114


title: breast cancer US073

tag: pcr (1) vs rd (0)

tag: tx.score (lower score, greater chemo sensitive)

tag: tfec.score (lower score, greater chemo sensitive)

tag: mammaprint.score (lower score, greater chemo sensitive)

tag: ror.s.score (higher score, greater chemo sensitive)

tag: ror.p.score (higher score, greater chemo sensitive)

tag: prechemo t


title: Breast cancer tumor OU-94

tag: age


title: Breast cancer tumor OU-101

tag: clinical t stage


title: Breast cancer tumor OU-99

tag: lymph node status


title: Breast cancer tumor OU-102

tag: clinical stage


title: Breast cancer tumor OU-110

tag: histological grade


title: breast cancer US001

tag: fec.score (lower score, greater chemo sensitive)

tag: prechemo n

tag: prechemo n.status (1

tag: er.status (1

tag: pr.status (1

tag: her2.status (1


title: Breast cancer tumor OU-106

tag: tissue

tag: er status ihc

tag: pr status ihc

tag: her2 status fish

tag: pathologic response pcr ncr


title: Breast cancer tumor OU-103


title: Breast cancer tumor OU-97


title: Breast cancer tumor OU-109


title: Breast cancer tumor OU-95


title: Breast cancer tumor OU-88


title: Breast cancer tumor OU-93

value: IIIB


title: Breast cancer tumor OU-92


title: Breast cancer tumor OU-89

value: IIIA


title: breast cancer US115

tag: pcr (1) vs rd (0)

tag: tx.score (lower score, greater chemo sensitive)

tag: tfec.score (lower score, greater chemo sensitive)

tag: mammaprint.score (lower score, greater chemo sensitive)

tag: ror.s.score (higher score, greater chemo sensitive)

tag: ror.p.score (higher score, greater chemo sensitive)

tag: prechemo t


title: Breast cancer tumor OU-91

tag: age

tag: clinical t stage

tag: lymph node status

tag: clinical stage

tag: histological grade


title: Breast cancer tumor OU-87

tag: tissue


title: Breast cancer tumor OU-80

tag: er status ihc


title: Breast cancer tumor OU-104

tag: pr status ihc


title: Breast cancer tumor OU-86

tag: her2 status fish


title: Breast cancer tumor OU-96

tag: pathologic response pcr ncr


title: Breast cancer tumor OU-76


title: Breast cancer tumor OU-78


title: Breast cancer tumor OU-85


title: Breast cancer tumor OU-82


title: Breast cancer tumor OU-71


title: Breast cancer tumor OU-81


title: Breast cancer tumor OU-84


title: Breast cancer tumor OU-83


title: Breast cancer tumor OU-73


title: Breast cancer tumor OU-75


title: Breast cancer tumor OU-70


title: Breast cancer tumor OU-64


title: Breast cancer tumor OU-59


title: Breast cancer tumor OU-63


title: Breast cancer tumor OU-77


title: Breast cancer tumor OU-79


title: Breast cancer tumor OU-54


title: Breast cancer tumor OU-68


title: Breast cancer tumor OU-67


title: Breast cancer tumor OU-66


title: Breast cancer tumor OU-58


title: Breast cancer tumor OU-52


title: Breast cancer tumor OU-69


title: Breast cancer tumor OU-72


title: Breast cancer tumor OU-60


title: Breast cancer tumor OU-57


title: Breast cancer tumor OU-61


title: Breast cancer tumor OU-65


title: Breast cancer tumor OU-74


title: Breast cancer tumor OU-90


title: Breast cancer tumor OU-49


title: Breast cancer tumor OU-47


title: Breast cancer tumor OU-53


title: Breast cancer tumor OU-50


title: Breast cancer tumor OU-46


title: Breast cancer tumor OU-43


title: Breast cancer tumor OU-56


title: Breast cancer tumor OU-44


title: Breast cancer tumor OU-55


title: Breast cancer tumor OU-62


title: Breast cancer tumor OU-48


title: Breast cancer tumor OU-39


title: Breast cancer tumor OU-51


title: Breast cancer tumor OU-45


title: Breast cancer tumor OU-35


title: Breast cancer tumor OU-36


title: Breast cancer tumor OU-40


title: Breast cancer tumor OU-37


title: Breast cancer tumor OU-33


title: Breast cancer tumor OU-42


title: Breast cancer tumor OU-34


title: Breast cancer tumor OU-30


title: Breast cancer tumor OU-38


title: Breast cancer tumor OU-28


title: Breast cancer tumor OU-25


title: Breast cancer tumor OU-41


title: Breast cancer tumor OU-32


title: Breast cancer tumor OU-29


title: Breast cancer tumor OU-26


title: Breast cancer tumor OU-27


title: Breast cancer tumor OU-31


title: Breast cancer tumor OU-22


title: Breast cancer tumor OU-12


title: Breast cancer tumor OU-16


title: Breast cancer tumor OU-23


title: Breast cancer tumor OU-21


title: Breast cancer tumor OU-24


title: Breast cancer tumor OU-14


title: Breast cancer tumor OU-15


title: Breast cancer tumor OU-17


title: Breast cancer tumor OU-19


title: Breast cancer tumor OU-20


title: Breast cancer tumor OU-9


title: Breast cancer tumor OU-11


title: Breast cancer tumor OU-1


title: Breast cancer tumor OU-4


title: Breast cancer tumor OU-6


title: Breast cancer tumor OU-2


title: Breast cancer tumor OU-7


title: Breast cancer tumor OU-13


title: Breast cancer tumor OU-18


title: Breast cancer tumor OU-3


title: Breast cancer tumor OU-5


title: Breast cancer tumor OU-10


title: Breast cancer tumor OU-8


title: HOVON65_GMMG_HD4_PC_EMC_000008

status: Public on Feb 01 2012

city: Rotterdam

first: Mark

last: van Duin

address: Wytemaweg 80

country: Netherlands

institute: Erasmus MC

description: multiple myeloma samples taken at diagnosis ; patients enrolled in  HOVON65/GMMG-HD4 trial

hyb_protocol: 15 ug of fragmented and biotin labeled cRNA was hybridized to gene arrays in accordance with Affymetrix protocols.

scan_protocol: Affymetrix 7G, GCOS 1.4

data_processing: Bioconductor Affy MAS5

source_name: CD138 purified myeloma cells

label_protocol: Affymetrix 2-Cycle Eukaryotic Target Labeling Assay

extract_protocol: Qiagen DNA/RNA prep kit

tag: tissue origin

value: bone marrow

tag: cell type

value: CD138 purified myeloma cells

tag: Stage

tag: cluster

value: HY

tag: iss

value: I


title: HOVON65_GMMG_HD4_PC_EMC_000006


title: HOVON65_GMMG_HD4_PC_EMC_000007

value: nd


title: HOVON65_GMMG_HD4_PC_EMC_000005

value: Myeloid


title: HOVON65_GMMG_HD4_PC_EMC_000004

value: NFkB

value: III


title: HOVON65_GMMG_HD4_PC_EMC_000003


title: HOVON65_GMMG_HD4_PC_EMC_000001

value: II


title: HOVON65_GMMG_HD4_PC_EMC_000002


title: 233358-2008

status: Public on Jan 13 2012

city: Chapel Hill

first: Charles

middle: M.

last: Perou

state: NC

address: 12-044 Lineberger Comprehensive Cancer Center CB# 7295

department: Professor of Genetics, and Pathology & Laboratory Medicine; Lineberger Comprehensive Cancer Center

institute: University of North Carolina at Chapel Hill

hyb_protocol: described in Hu et al., 2005, BioTechniques, 38:121-124

scan_protocol: Fluorescent array images were collected for both Cy3 and Cy5 with a GenePix 4000B fluorescent scanner and image intensity data were extracted and analyzed with GenePix Pro 5.1 analysis software.

data_processing: Data for both channels were Lowess-normalized and then log(2) ratio was taken

source_name: Human Reference B

extract_protocol: Total RNA isolated by stratagene

tag: reference

value: Stratagene Human Universal Reference that contained 1/10 added MCF7 and ME16C RNAs

extract_protocol: Qiagen Rneasy Kit

tag: slide name

tag: i-spy id

tag: experiment name

tag: study

value: ISPY

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 4=indeterminate)

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other 6=no invasive tumor present;)

tag: clinical tumor size (pre-chemotherapy), cm (-1 = n/a)

tag: clinical t stage (pre-chemotherapy) (1 = <= 2cm; 2 = >2-5 cm; 3 = > 5cm)

tag: er (0=negative; 1=positive;)

tag: pgr  (0=negative; 1=positive;)

tag: her2 (0=negative; 1=positive;)

tag: intrinsic subtype by pam50

value: Luminal A

tag: neoadjuvant chemotherapy* (1 = ac only; 2 = ac + t; 3 = ac + t + herceptin; 4 = ac + t + other;)

value: A = doxorubicin, C = Cyclophosphamide, T = taxane:2

tag: pathological complete response (pcr)

value: No

tag: rcb class

value: II=RCB index greater than 1.36 or equal to 3.28

tag: relapse-free survival time – time from chemo start date until earliest

value: local or distant progression or death (time unit is days):1224

tag: relapse-free survival indicator (1=event; local or distant progression or death, 0=censor at last follow-up)

tag: overall survival - time from study chemo start date to death or last follow-up; (time unit is days)

tag: survival status (7=alive; 8=dead, 9=lost)


title: 220072-2008

label_protocol: described in Hu et al., 2005, BioTechniques, 38:121-124

tag: reference

tag: slide name

tag: i-spy id

tag: experiment name

tag: age

value: Basal-like

value: Yes

value: 0=RCB index 0

value: local or distant progression or death (time unit is days):1725


title: 243158-2008

tag: study

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 4=indeterminate)

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other 6=no invasive tumor present;)

tag: clinical tumor size (pre-chemotherapy), cm (-1 = n/a)

tag: clinical t stage (pre-chemotherapy) (1 = <= 2cm; 2 = >2-5 cm; 3 = > 5cm)

value: local or distant progression or death (time unit is days):1332


title: 234844-2008

tag: er (0=negative; 1=positive;)

tag: pgr  (0=negative; 1=positive;)

tag: her2 (0=negative; 1=positive;)

tag: intrinsic subtype by pam50

tag: neoadjuvant chemotherapy* (1 = ac only; 2 = ac + t; 3 = ac + t + herceptin; 4 = ac + t + other;)

value: A = doxorubicin, C = Cyclophosphamide, T = taxane:3

value: local or distant progression or death (time unit is days):1564


title: breast cancer MEXICO10

status: Public on Jun 29 2011

first: TAKAYUKI

last: IWAMOTO

address: 1515 Holcombe Blvd

department: Breast medical Oncology

institute: UT MD Anderson

description:
Gene expression data from breast cancer FNA biopsy, pre-treatment
Characteristics legend:
pCR: pathologic complete response was defined as no residual invasive cancer in the breast and lymph nodes after preoperative chemotherapy.
RD: residual disease was defined as any degree of invasive cancer that survived preoperative chemotherapy.
Prechemo T and Prechemo N: were modified by TNM staging system in the American Joint Committee on Cancer
Prechemo Tumor size: Clinical tumor size
BMN.grade: were modified by Black's Nuclear Grade

data_processing: The data were normalized using dChip version 1.3 followed by logrithm-base-2 sc600 transformation. The dChip version 1.3 was used to calculate Model Based Expression Index (MBEI) values of the arrays using the digital standard microarray MDA-BCNorm.CEL and the probe sensitivity index file UTMDACC-BreastCancerNormalizer.psi as described in Hess, et. al, Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and 5-Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer, Journal of Clinical Oncology, 24 (26), 2006.

treatment_protocol: Patients received neoadjuvant chemotherapy regimen with 5-Fluorouracil, Doxorubicin (Epirubicin) and Cyclophosphamide

tag: tissue

value: breast cancer FNA biopsy

value: RD

value: Pass

tag: p53 status

value: WT

tag: er positive vs negative by esr1 mrna gene expression (probe

tag: er positive vs negative by immunohistochemistry

value: ERneg

tag: prechemo t

tag: postchemo tumor size

tag: prechemo n


title: breast cancer X439

value: MUT

tag: age


title: breast cancer MEXICO9


title: breast cancer X553


title: 228171-2008

tag: reference

value: Stratagene Human Universal Reference that contained 1/10 added MCF7 and ME16C RNAs

tag: slide name

tag: i-spy id

tag: experiment name

tag: study

value: ISPY

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 4=indeterminate)

value: Luminal A

value: A = doxorubicin, C = Cyclophosphamide, T = taxane:2

tag: pathological complete response (pcr)

tag: rcb class

tag: relapse-free survival time – time from chemo start date until earliest

value: local or distant progression or death (time unit is days):1485

tag: relapse-free survival indicator (1=event; local or distant progression or death, 0=censor at last follow-up)

tag: overall survival - time from study chemo start date to death or last follow-up; (time unit is days)

tag: survival status (7=alive; 8=dead, 9=lost)


title: 229104-2008

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other 6=no invasive tumor present;)

tag: clinical tumor size (pre-chemotherapy), cm (-1 = n/a)

tag: clinical t stage (pre-chemotherapy) (1 = <= 2cm; 2 = >2-5 cm; 3 = > 5cm)

tag: er (0=negative; 1=positive;)

tag: pgr  (0=negative; 1=positive;)

tag: her2 (0=negative; 1=positive;)

tag: intrinsic subtype by pam50

tag: neoadjuvant chemotherapy* (1 = ac only; 2 = ac + t; 3 = ac + t + herceptin; 4 = ac + t + other;)

value: No

value: III=RCB index greater than 3.28

value: local or distant progression or death (time unit is days):1816


title: 226218-2008

tag: reference

tag: slide name

tag: i-spy id

tag: experiment name

tag: age

value: Luminal B

value: I=RCB index less than or equal to 1.36

value: local or distant progression or death (time unit is days):1432


title: 241894-2008

tag: study

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 4=indeterminate)

tag: pathological complete response (pcr)

tag: rcb class

value: Unavailable

tag: relapse-free survival time – time from chemo start date until earliest

value: local or distant progression or death (time unit is days):1213


title: breast cancer X150

tag: tissue

value: breast cancer FNA biopsy

value: RD

value: Pass

tag: p53 status

tag: er positive vs negative by esr1 mrna gene expression (probe

tag: er positive vs negative by immunohistochemistry

tag: prechemo t

tag: postchemo tumor size

tag: prechemo n


title: 254448-2008

tag: reference

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other 6=no invasive tumor present;)

tag: clinical tumor size (pre-chemotherapy), cm (-1 = n/a)

tag: clinical t stage (pre-chemotherapy) (1 = <= 2cm; 2 = >2-5 cm; 3 = > 5cm)

tag: er (0=negative; 1=positive;)

tag: pgr  (0=negative; 1=positive;)

tag: her2 (0=negative; 1=positive;)

tag: intrinsic subtype by pam50

tag: neoadjuvant chemotherapy* (1 = ac only; 2 = ac + t; 3 = ac + t + herceptin; 4 = ac + t + other;)

value: II=RCB index greater than 1.36 or equal to 3.28

value: local or distant progression or death (time unit is days):1251

tag: relapse-free survival indicator (1=event; local or distant progression or death, 0=censor at last follow-up)

tag: overall survival - time from study chemo start date to death or last follow-up; (time unit is days)

tag: survival status (7=alive; 8=dead, 9=lost)


title: breast cancer X452

tag: tissue

tag: p53 status

value: MUT

tag: er positive vs negative by esr1 mrna gene expression (probe

tag: age


title: 238046-2008

value: Stratagene Human Universal Reference that contained 1/10 added MCF7 and ME16C RNAs

tag: slide name

tag: i-spy id

tag: experiment name

tag: study

value: ISPY

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 4=indeterminate)

value: Basal-like

tag: pathological complete response (pcr)

tag: rcb class

tag: relapse-free survival time – time from chemo start date until earliest

value: local or distant progression or death (time unit is days):1379


title: 244257-2008

tag: reference

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other 6=no invasive tumor present;)

tag: clinical tumor size (pre-chemotherapy), cm (-1 = n/a)

tag: clinical t stage (pre-chemotherapy) (1 = <= 2cm; 2 = >2-5 cm; 3 = > 5cm)

tag: er (0=negative; 1=positive;)

tag: pgr  (0=negative; 1=positive;)

tag: her2 (0=negative; 1=positive;)

tag: intrinsic subtype by pam50

value: Luminal A

value: A = doxorubicin, C = Cyclophosphamide, T = taxane:2

value: No

value: local or distant progression or death (time unit is days):1002


title: breast cancer FA46

tag: tissue

tag: p53 status

tag: er positive vs negative by esr1 mrna gene expression (probe

tag: er positive vs negative by immunohistochemistry

tag: age

tag: prechemo t

tag: postchemo tumor size

tag: prechemo n


title: 229879-2008

tag: slide name

tag: i-spy id

tag: experiment name

tag: study

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 4=indeterminate)

tag: neoadjuvant chemotherapy* (1 = ac only; 2 = ac + t; 3 = ac + t + herceptin; 4 = ac + t + other;)

tag: pathological complete response (pcr)

tag: rcb class

tag: relapse-free survival time – time from chemo start date until earliest

value: local or distant progression or death (time unit is days):1204

tag: relapse-free survival indicator (1=event; local or distant progression or death, 0=censor at last follow-up)

tag: overall survival - time from study chemo start date to death or last follow-up; (time unit is days)

tag: survival status (7=alive; 8=dead, 9=lost)


title: breast cancer FA39

tag: tissue

value: pCR

tag: p53 status

tag: er positive vs negative by esr1 mrna gene expression (probe

tag: er positive vs negative by immunohistochemistry

value: ERneg


title: 235593-2008

tag: reference

tag: age

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other 6=no invasive tumor present;)

tag: clinical tumor size (pre-chemotherapy), cm (-1 = n/a)

tag: clinical t stage (pre-chemotherapy) (1 = <= 2cm; 2 = >2-5 cm; 3 = > 5cm)

tag: er (0=negative; 1=positive;)

tag: pgr  (0=negative; 1=positive;)

tag: her2 (0=negative; 1=positive;)

tag: intrinsic subtype by pam50

value: A = doxorubicin, C = Cyclophosphamide, T = taxane:3

value: Yes

value: 0=RCB index 0

value: local or distant progression or death (time unit is days):1518


title: breast cancer FA51

value: breast cancer FNA biopsy

value: RD

value: Pass

value: WT

tag: prechemo t

tag: postchemo tumor size

tag: prechemo n


title: 235160-2008

value: Stratagene Human Universal Reference that contained 1/10 added MCF7 and ME16C RNAs

tag: slide name

tag: i-spy id

tag: experiment name

tag: study

value: ISPY

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 4=indeterminate)

value: Luminal B

tag: neoadjuvant chemotherapy* (1 = ac only; 2 = ac + t; 3 = ac + t + herceptin; 4 = ac + t + other;)

tag: pathological complete response (pcr)

tag: rcb class

value: II=RCB index greater than 1.36 or equal to 3.28

tag: relapse-free survival time – time from chemo start date until earliest

value: local or distant progression or death (time unit is days):1344

tag: relapse-free survival indicator (1=event; local or distant progression or death, 0=censor at last follow-up)

tag: overall survival - time from study chemo start date to death or last follow-up; (time unit is days)

tag: survival status (7=alive; 8=dead, 9=lost)


title: 254545-2008

tag: reference

tag: age

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other 6=no invasive tumor present;)

tag: clinical tumor size (pre-chemotherapy), cm (-1 = n/a)

tag: clinical t stage (pre-chemotherapy) (1 = <= 2cm; 2 = >2-5 cm; 3 = > 5cm)

tag: er (0=negative; 1=positive;)

tag: pgr  (0=negative; 1=positive;)

tag: her2 (0=negative; 1=positive;)

value: Basal-like

value: A = doxorubicin, C = Cyclophosphamide, T = taxane:2

value: No

value: I=RCB index less than or equal to 1.36

value: local or distant progression or death (time unit is days):1307


title: 229507-2008

tag: slide name

tag: i-spy id

tag: experiment name

tag: study

tag: intrinsic subtype by pam50

value: Luminal A

value: A = doxorubicin, C = Cyclophosphamide, T = taxane:3

value: local or distant progression or death (time unit is days):1393


title: 228306-2008

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 4=indeterminate)

tag: neoadjuvant chemotherapy* (1 = ac only; 2 = ac + t; 3 = ac + t + herceptin; 4 = ac + t + other;)

tag: pathological complete response (pcr)

tag: rcb class

tag: relapse-free survival time – time from chemo start date until earliest

value: local or distant progression or death (time unit is days):677


title: 233169-2008

tag: reference

tag: age

value: Yes

value: 0=RCB index 0

value: local or distant progression or death (time unit is days):1280

tag: relapse-free survival indicator (1=event; local or distant progression or death, 0=censor at last follow-up)

tag: overall survival - time from study chemo start date to death or last follow-up; (time unit is days)

tag: survival status (7=alive; 8=dead, 9=lost)


title: 235740-2008

value: Stratagene Human Universal Reference that contained 1/10 added MCF7 and ME16C RNAs

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other 6=no invasive tumor present;)

tag: clinical tumor size (pre-chemotherapy), cm (-1 = n/a)

tag: clinical t stage (pre-chemotherapy) (1 = <= 2cm; 2 = >2-5 cm; 3 = > 5cm)

tag: er (0=negative; 1=positive;)

tag: pgr  (0=negative; 1=positive;)

value: III=RCB index greater than 3.28

value: local or distant progression or death (time unit is days):1190


title: breast cancer FA34

tag: tissue

value: breast cancer FNA biopsy

value: pCR

value: Pass

tag: p53 status

value: WT

tag: er positive vs negative by esr1 mrna gene expression (probe

tag: er positive vs negative by immunohistochemistry

value: ERneg

tag: prechemo t

tag: postchemo tumor size

tag: prechemo n


title: 229123-2008

tag: reference

tag: slide name

tag: i-spy id

tag: experiment name

tag: study

value: ISPY

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 4=indeterminate)

tag: her2 (0=negative; 1=positive;)

tag: intrinsic subtype by pam50

tag: neoadjuvant chemotherapy* (1 = ac only; 2 = ac + t; 3 = ac + t + herceptin; 4 = ac + t + other;)

value: A = doxorubicin, C = Cyclophosphamide, T = taxane:2

tag: pathological complete response (pcr)

value: No

tag: rcb class

tag: relapse-free survival time – time from chemo start date until earliest

value: local or distant progression or death (time unit is days):1719


title: breast cancer FA30

tag: tissue

value: RD

tag: p53 status

value: MUT

tag: er positive vs negative by esr1 mrna gene expression (probe

tag: age


title: breast cancer FA27

tag: er positive vs negative by immunohistochemistry

value: ERpos

tag: prechemo t

tag: postchemo tumor size

tag: prechemo n


title: breast cancer FA26


title: breast cancer FA12


title: breast cancer FA08


title: breast cancer FA22


title: breast cancer FA10


title: breast cancer FA05


title: breast cancer FA20


title: breast cancer FA02


title: Spain-1794948

status: Public on May 27 2011

tag: reference

value: Madrid

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 9 = n/a)

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other  6=no invasive tumor present; 9 = n/a )

tag: tumor size (pre-chemotherapy), cm (-1 = n/a)

tag: er (0=negative; 1=positive; 9 = n/a)

tag: pgr  (0=negative; 1=positive; 9 = n/a)

tag: her2 (0=negative; 1=positive; 9 = n/a)

tag: pam50 + claudin-low

value: Basal

tag: neoadjuvant chemotherapy

value: Doxorubicin

tag: number of positive nodes (post chemotherapy)

tag: pcr

tag: residual cancer burden index class

value: III


title: Spain-547202

value: Stratagene Human Universal Reference that contained 1/10 added MCF7 and ME16C RNAs

tag: study

tag: age

value: Claudin


title: breast cancer FA09

tag: tissue

value: breast cancer FNA biopsy

tag: p53 status

tag: er positive vs negative by esr1 mrna gene expression (probe

tag: er positive vs negative by immunohistochemistry

tag: prechemo t


title: Spain-272042

tag: reference

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 9 = n/a)

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other  6=no invasive tumor present; 9 = n/a )

value: Luminal A


title: Spain-1637962

tag: tumor size (pre-chemotherapy), cm (-1 = n/a)

tag: er (0=negative; 1=positive; 9 = n/a)

tag: pgr  (0=negative; 1=positive; 9 = n/a)

value: Taxane

value: II


title: Spain-1791942

tag: her2 (0=negative; 1=positive; 9 = n/a)

tag: pam50 + claudin-low

value: Luminal B

tag: neoadjuvant chemotherapy


title: Spain-778076

tag: number of positive nodes (post chemotherapy)

tag: pcr

tag: residual cancer burden index class


title: Spain-1477616

tag: study

tag: age

value: I


title: Spain-1522373

value: No


title: Spain-1768165


title: Spain-1605740


title: Spain-1481343

value: Normal


title: Spain-1771131


title: Spain-1457287


title: Spain-687429


title: Spain-1741358


title: Spain-1050665


title: Spain-1664080


title: Spain-1761110


title: Spain-520791

value: Yes


title: Spain-980114


title: Spain-876606


title: Spain-837912


title: Spain-1682730


title: Spain-895708


title: Spain-715054


title: Spain-1683225


title: Spain-185640


title: Spain-1829604


title: Spain-1734658


title: Spain-1810390


title: Spain-641963


title: Spain-1844864


title: Spain-1743648


title: Spain-1766842


title: Spain-1722086


title: Spain-263867


title: Spain-1226539


title: Spain-1839707


title: Spain-262222


title: Spain-1821582


title: Spain-822554


title: Spain-1401484


title: Spain-1125114


title: Spain-799011


title: Spain-1794002


title: Spain-1811301


title: Spain-883555


title: Spain-1532699


title: Spain-1215966


title: Spain27

status: Public on May 11 2011

city: Woburn

first: Christos

last: Hatzis

state: MA

address: 400 West Cummings Park, Suite 5350

institute: Nuvera Biosciences

hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized overnight at 46C on Affymetrix U133A arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: GeneChips were scanned using the diagnostic-grade Affymetrix scanner 3000DX

data_processing: Probe intensities were quantified with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings.  CEL files were normalized using global scaling with a trimmed mean target intensity of each array arbitrarily set to 600 using the MAS5 algorithm from the simpleaffy package (http://bioconductor.org/packages/2.4/bioc/html/simpleaffy.html).

source_name: breast cancer, sample LBJ/IN/GEI-Spain27

label_protocol: A single-round T7 amplification was used to generate biotin-labeled cRNA for hybridization.  At least 1 ug of RNA is required for cRNA synthesis.

extract_protocol: Total RNA was extracted from tissue using Qiagen Rneasy columns

treatment_protocol: Patients prospectively consented to a research biopsy by fine needle aspiration (FNA) or  core biopsy (CBX) prior to any systemic therapy, and to the future assessment of pathologic  response and/or survival endpoints

tag: sample id

tag: source

value: LBJ/IN/GEI

value: P

value: N

value: IIA

tag: grade

value: RD

value: Taxol

value: SET-Low

value: Rx Insensitive

value: Low

value: LumA

value: RCB-II/III

tag: tissue

value: breast cancer tumor


title: Spain51

source_name: breast cancer, sample LBJ/IN/GEI-Spain51

value: IIIA

value: RCB-II

value: SET-Int

value: Rx Sensitive


title: Spain49

source_name: breast cancer, sample LBJ/IN/GEI-Spain49

value: IIB

value: RCB-III

value: High


title: Spain57

source_name: breast cancer, sample LBJ/IN/GEI-Spain57

value: LBJ/IN/GEI

value: N

value: P


title: Spain-1573436

tag: reference

value: Stratagene Human Universal Reference that contained 1/10 added MCF7 and ME16C RNAs

value: Madrid

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 9 = n/a)

value: Basal

value: Doxorubicin

value: No

value: II


title: Spain53

source_name: breast cancer, sample LBJ/IN/GEI-Spain53

value: RD

value: Taxol

value: SET-Low

value: Rx Insensitive

value: Low

value: Normal

value: pCR

value: RCB-II/III

value: breast cancer tumor


title: Spain-1702703

tag: histology (1=necrosis; 2=ductal carcinoma; 3=lobular; 4=mixed ductal/lobular carcinoma; 5=other  6=no invasive tumor present; 9 = n/a )

tag: tumor size (pre-chemotherapy), cm (-1 = n/a)

value: Taxane

value: Yes


title: Spain12

source_name: breast cancer, sample LBJ/IN/GEI-Spain12

value: LBJ/IN/GEI

value: P

value: N

value: IIA

value: RCB-II

value: LumA


title: PERU76

source_name: breast cancer, sample LBJ/IN/GEI-PERU76

value: IIIB

value: RD

value: RCB-III

value: High


title: Spain04

source_name: breast cancer, sample LBJ/IN/GEI-Spain04

value: IIB

value: Taxol

value: SET-Low

value: Rx Insensitive

value: Basal


title: Spain46

source_name: breast cancer, sample LBJ/IN/GEI-Spain46

value: IIIA

value: SET-Int

value: Rx Sensitive

value: RCB-II/III

value: breast cancer tumor


title: Spain48

source_name: breast cancer, sample LBJ/IN/GEI-Spain48

value: LBJ/IN/GEI

value: N

value: IIA

value: pCR

value: P

value: Low

value: Normal


title: Spain45

source_name: breast cancer, sample LBJ/IN/GEI-Spain45

value: IIIB

value: High

value: RD


title: PERU73

source_name: breast cancer, sample LBJ/IN/GEI-PERU73

value: RCB-III

value: Taxol

value: SET-Low

value: Rx Insensitive

value: LumA


title: Spain07

source_name: breast cancer, sample LBJ/IN/GEI-Spain07

value: RCB-II

value: Basal


title: Spain06

source_name: breast cancer, sample LBJ/IN/GEI-Spain06

value: LBJ/IN/GEI

value: LumB

value: RCB-II/III

value: breast cancer tumor


title: Spain32

source_name: breast cancer, sample LBJ/IN/GEI-Spain32

value: P

value: N

value: IIIA


title: Spain-1671347

value: Stratagene Human Universal Reference that contained 1/10 added MCF7 and ME16C RNAs

value: Madrid

tag: er (0=negative; 1=positive; 9 = n/a)

tag: pgr  (0=negative; 1=positive; 9 = n/a)

value: Doxorubicin

value: No

value: III


title: Spain-1100262

tag: her2 (0=negative; 1=positive; 9 = n/a)

tag: pam50 + claudin-low

value: Luminal B

value: II


title: Spain-81737

tag: neoadjuvant chemotherapy

value: Taxane

tag: number of positive nodes (post chemotherapy)


title: Spain-1858833

tag: pcr

tag: residual cancer burden index class


title: Spain-1560013

tag: study

tag: age

value: Luminal A


title: Spain-929314

value: Yes


title: Spain-724647

value: Basal


title: Spain13

source_name: breast cancer, sample LBJ/IN/GEI-Spain13

tag: sample id

tag: source

value: LBJ/IN/GEI

value: IIB

value: RD

value: RCB-II

value: Taxol

value: SET-Int

value: Rx Sensitive

value: Low

value: Normal


title: Spain41

source_name: breast cancer, sample LBJ/IN/GEI-Spain41

value: P

value: N

value: IIIA

tag: grade

value: SET-Low

value: Rx Insensitive

value: High

value: LumB

value: RCB-II/III

tag: tissue

value: breast cancer tumor


title: Spain30

source_name: breast cancer, sample LBJ/IN/GEI-Spain30

value: LBJ/IN/GEI

value: LumA


title: Spain-1413740

source_name: Human Reference B

tag: reference

value: Stratagene Human Universal Reference that contained 1/10 added MCF7 and ME16C RNAs

value: Madrid

tag: histologic grade (1=grade i (low);  2= grade ii (intermediate); 3= grade iii (high); 9 = n/a)

value: Basal

value: Taxane

value: Yes


title: PERU72

source_name: breast cancer, sample LBJ/IN/GEI-PERU72

value: IIIB

value: RD

value: RCB-III

value: Taxol


title: PERU50

source_name: breast cancer, sample LBJ/IN/GEI-PERU50

value: P

value: N

value: IIIA

value: pCR

value: SET-Low


title: PERU61

source_name: breast cancer, sample LBJ/IN/GEI-PERU61

value: RCB-II

value: Rx Insensitive

value: Low

value: LumB

value: RCB-II/III

value: breast cancer tumor


title: PERU52

source_name: breast cancer, sample LBJ/IN/GEI-PERU52

value: LBJ/IN/GEI

value: Rx Sensitive

value: High


title: PERU40

source_name: breast cancer, sample LBJ/IN/GEI-PERU40

value: Basal


title: PERU53

source_name: breast cancer, sample LBJ/IN/GEI-PERU53

value: RD


title: PERU38

source_name: breast cancer, sample LBJ/IN/GEI-PERU38

value: IIIB

value: RCB-III

value: Taxol

value: LumA


title: PERU57

source_name: breast cancer, sample LBJ/IN/GEI-PERU57

value: P

value: N

value: SET-Int


title: PERU28

source_name: breast cancer, sample LBJ/IN/GEI-PERU28

value: SET-Low

value: Rx Insensitive


title: PERU16-18

source_name: breast cancer, sample LBJ/IN/GEI-PERU16-18

value: Low


title: PERU42

source_name: breast cancer, sample LBJ/IN/GEI-PERU42

value: RCB-II/III


title: PERU54

source_name: breast cancer, sample LBJ/IN/GEI-PERU54

value: pCR

value: breast cancer tumor


title: PERU48

source_name: breast cancer, sample LBJ/IN/GEI-PERU48

value: LBJ/IN/GEI

value: IIIC


title: LBJ158

source_name: breast cancer, sample LBJ/IN/GEI-LBJ158

value: High


title: PERU56

source_name: breast cancer, sample LBJ/IN/GEI-PERU56

value: RD

value: Basal


title: LBJ103

source_name: breast cancer, sample LBJ/IN/GEI-LBJ103

value: IIB

value: RCB-II

value: LumB


title: PERU37

source_name: breast cancer, sample LBJ/IN/GEI-PERU37

value: P

value: IIIB

value: RCB-III

value: Taxol


title: PERU26

source_name: breast cancer, sample LBJ/IN/GEI-PERU26

value: N

value: SET-Low

value: Rx Insensitive


title: PERU05

source_name: breast cancer, sample LBJ/IN/GEI-PERU05


title: PERU21

source_name: breast cancer, sample LBJ/IN/GEI-PERU21

value: IIIA

value: Rx Sensitive


title: LBJ131

source_name: breast cancer, sample LBJ/IN/GEI-LBJ131

value: LBJ/IN/GEI

value: Normal

value: RCB-II/III

value: breast cancer tumor


title: PERU44

source_name: breast cancer, sample LBJ/IN/GEI-PERU44

value: RD

value: High

value: Basal

value: pCR


title: LBJ143

source_name: breast cancer, sample LBJ/IN/GEI-LBJ143

value: IIB

value: RCB-II

value: P

value: Low


title: PERU23

source_name: breast cancer, sample LBJ/IN/GEI-PERU23

value: N

value: IIIB

value: Taxol


title: LBJ170

source_name: breast cancer, sample LBJ/IN/GEI-LBJ170

value: SET-Low

value: Rx Insensitive


title: LBJ171

source_name: breast cancer, sample LBJ/IN/GEI-LBJ171

value: LBJ/IN/GEI

value: IIIA

value: RCB-III


title: LBJ082

source_name: breast cancer, sample LBJ/IN/GEI-LBJ082

value: Normal

value: RCB-II/III

value: breast cancer tumor


title: LBJ070

source_name: breast cancer, sample LBJ/IN/GEI-LBJ070

value: RD

value: Rx Sensitive

value: High


title: PERU02

source_name: breast cancer, sample LBJ/IN/GEI-PERU02

value: RCB-II

value: LumB


title: PERU06

source_name: breast cancer, sample LBJ/IN/GEI-PERU06

value: P


title: LBJ054

source_name: breast cancer, sample LBJ/IN/GEI-LBJ054

value: N

value: IIA

value: Low

value: LumA


title: LBJ105

source_name: breast cancer, sample LBJ/IN/GEI-LBJ105

value: pCR

value: Taxol

value: SET-Low

value: Rx Insensitive


title: LBJ046

source_name: breast cancer, sample LBJ/IN/GEI-LBJ046

value: LBJ/IN/GEI

value: IIIB

value: RCB-III


title: LBJ071

source_name: breast cancer, sample LBJ/IN/GEI-LBJ071

value: Normal

value: RD

value: RCB-II/III

value: breast cancer tumor


title: LBJ053

source_name: breast cancer, sample LBJ/IN/GEI-LBJ053

value: IIIA

value: RCB-II

value: Taxotere

value: High

value: Basal


title: LBJ038

source_name: breast cancer, sample LBJ/IN/GEI-LBJ038

value: N

value: IIB


title: PERU69

source_name: breast cancer, sample LBJ/IN/GEI-PERU69

value: P

value: Taxol

value: LumB


title: LBJ047

source_name: breast cancer, sample LBJ/IN/GEI-LBJ047

value: LBJ/IN/GEI

value: IIA

value: pCR

value: SET-Low

value: Rx Insensitive


title: LBJ016

source_name: breast cancer, sample LBJ/IN/GEI-LBJ016

value: RD

value: RCB-II/III


title: LBJ032

source_name: breast cancer, sample LBJ/IN/GEI-LBJ032

value: IIIA

value: Low

value: LumA

value: breast cancer tumor


title: MDA018

source_name: breast cancer, sample MDACC-MDA018

value: MDACC

value: IIIC

value: Rx Sensitive


title: MDA013

source_name: breast cancer, sample MDACC-MDA013

value: N

value: IIB

value: P

value: Normal


title: MDA010

source_name: breast cancer, sample MDACC-MDA010

value: IIA

value: Taxol

value: High

value: Basal


title: MDA012

source_name: breast cancer, sample MDACC-MDA012

value: SET-High

value: RD


title: MDA015

source_name: breast cancer, sample MDACC-MDA015

value: SET-Int

value: RCB-II/III


title: MDA014

source_name: breast cancer, sample MDACC-MDA014

value: SET-Low

value: Low


title: MDA009

source_name: breast cancer, sample MDACC-MDA009

value: MDACC

value: IIIA

value: pCR

value: breast cancer tumor


title: MDA016

source_name: breast cancer, sample MDACC-MDA016

value: N

value: IIB

value: Rx Insensitive


title: MDA005

source_name: breast cancer, sample MDACC-MDA005

value: P

value: IIA

value: Taxotere

value: LumA


title: MDA008

source_name: breast cancer, sample MDACC-MDA008

value: Taxol

value: Rx Sensitive


title: MDA006

source_name: breast cancer, sample MDACC-MDA006

value: SET-Int

value: RD


title: MDA007

source_name: breast cancer, sample MDACC-MDA007

value: SET-Low

value: LumB


title: MDA011

source_name: breast cancer, sample MDACC-MDA011

value: MDACC

value: High

value: Basal


title: 896

source_name: breast cancer, sample MDACC-896

value: IIIA

value: RCB-II

value: Low

value: breast cancer tumor


title: 905

source_name: breast cancer, sample MDACC-905

value: P

value: N

value: RCB-II/III


title: 893

source_name: breast cancer, sample MDACC-893

value: IIA

value: Taxotere


title: 901

source_name: breast cancer, sample MDACC-901

value: IIB

value: Taxol

value: Rx Insensitive

value: LumA


title: MDA003

source_name: breast cancer, sample MDACC-MDA003

value: I

value: SET-Low

value: pCR


title: 910

source_name: breast cancer, sample MDACC-910

value: MDACC

value: IIIC

value: RD

value: RCB-III

value: High


title: 913

source_name: breast cancer, sample MDACC-913

value: P

value: RCB-II

value: breast cancer tumor


title: 916

source_name: breast cancer, sample MDACC-916

value: N

value: IIIA

value: Basal

value: RCB-II/III


title: MDA002

source_name: breast cancer, sample MDACC-MDA002

value: Taxol

value: SET-Int

value: Rx Sensitive

value: Low


title: 883

source_name: breast cancer, sample MDACC-883

value: I

value: Taxotere

value: SET-Low

value: Rx Insensitive

value: LumA


title: 885

source_name: breast cancer, sample MDACC-885

value: MDACC

value: IIIC

value: RD

value: RCB-III

value: High

value: Normal

value: pCR


title: 881

source_name: breast cancer, sample MDACC-881

value: N

value: IIA

value: breast cancer tumor


title: 886

source_name: breast cancer, sample MDACC-886

value: P

value: RCB-II

value: Taxol

value: SET-High

value: Rx Sensitive

value: RCB-II/III


title: 892

source_name: breast cancer, sample MDACC-892

value: SET-Low

value: Rx Insensitive

value: Basal


title: 868

source_name: breast cancer, sample MDACC-868

value: MDACC

value: RD


title: 879

source_name: breast cancer, sample MDACC-879

value: IIIC

value: High


title: 880

source_name: breast cancer, sample MDACC-880

value: Taxotere

value: Low

value: LumA


title: 842

source_name: breast cancer, sample MDACC-842

value: N

value: IIA

value: breast cancer tumor


title: 867

source_name: breast cancer, sample MDACC-867

value: P

value: RCB-II

value: Taxol

value: SET-Int


title: 860

source_name: breast cancer, sample MDACC-860

value: IIIB

value: Rx Sensitive

value: RCB-II/III


title: 839

source_name: breast cancer, sample MDACC-839

value: MDACC

value: IIIA

value: SET-Low

value: Rx Insensitive

value: Basal

value: pCR


title: 840

source_name: breast cancer, sample MDACC-840

value: High


title: 857

source_name: breast cancer, sample MDACC-857

value: N


title: 838

source_name: breast cancer, sample MDACC-838

value: IIA

value: RD

value: LumB


title: 837

source_name: breast cancer, sample MDACC-837

value: P

value: RCB-II

value: breast cancer tumor


title: 845

source_name: breast cancer, sample MDACC-845

value: IIB

value: Taxol


title: 835

source_name: breast cancer, sample MDACC-835

value: IIIB

value: RCB-III

value: SET-Int

value: Rx Sensitive

value: Low

value: LumA

value: RCB-II/III


title: 865

source_name: breast cancer, sample MDACC-865

value: MDACC

value: SET-Low

value: Rx Insensitive

value: High

value: Basal

value: pCR


title: 829

source_name: breast cancer, sample MDACC-829

value: N

value: IIIA


title: 831

source_name: breast cancer, sample MDACC-831

value: P

value: IIB

value: RD

value: RCB-II

value: breast cancer tumor


title: 825

source_name: breast cancer, sample MDACC-825

value: IIA

value: Taxol

value: Rx Sensitive


title: 815

source_name: breast cancer, sample MDACC-815

value: SET-Int

value: Low

value: LumA

value: RCB-II/III


title: 826

source_name: breast cancer, sample MDACC-826

value: MDACC

value: RCB-III

value: SET-Low

value: Rx Insensitive

value: High


title: 854

source_name: breast cancer, sample MDACC-854

value: P

value: N

value: pCR

value: LumB


title: 822

source_name: breast cancer, sample MDACC-822

value: IIB

value: RD

value: RCB-II

value: breast cancer tumor


title: 821

source_name: breast cancer, sample MDACC-821

value: IIA

value: Taxol


title: 660

source_name: breast cancer, sample MDACC-660

value: Taxotere

value: Low

value: LumA


title: 813

source_name: breast cancer, sample MDACC-813

value: MDACC

value: IIIA

value: Normal


title: 824

source_name: breast cancer, sample MDACC-824

value: IIIB

value: SET-Low

value: Rx Insensitive

value: High


title: 811

source_name: breast cancer, sample MDACC-811

value: N

value: Basal

value: pCR


title: 798

source_name: breast cancer, sample MDACC-798

value: RD

value: RCB-II


title: 817

source_name: breast cancer, sample MDACC-817

value: P

value: RCB-III

value: LumB

value: RCB-II/III

value: breast cancer tumor


title: 748

source_name: breast cancer, sample MDACC-748

value: MDACC

value: IIA

value: Taxol

value: Low

value: LumA


title: 787

source_name: breast cancer, sample MDACC-787

value: IIB

value: Taxotere

value: SET-Low

value: Rx Insensitive


title: 828

source_name: breast cancer, sample MDACC-828

value: N

value: IIIB

value: High


title: 814

source_name: breast cancer, sample MDACC-814

value: P

value: RD


title: 699

source_name: breast cancer, sample MDACC-699

value: RCB-III

value: Basal

value: pCR


title: 645

source_name: breast cancer, sample MDACC-645

value: MDACC

value: RCB-II/III

value: breast cancer tumor


title: 551

source_name: breast cancer, sample MDACC-551

value: RCB-II

value: LumB


title: 496

source_name: breast cancer, sample MDACC-496

value: IIB

value: Rx Sensitive

value: Low

value: LumA


title: 470

source_name: breast cancer, sample MDACC-470

value: N

value: IIA

value: Taxotere

value: SET-Low

value: Rx Insensitive

value: Normal


title: 575

source_name: breast cancer, sample MDACC-575

value: P

value: IIIA

value: RD

value: Taxol

value: High


title: 509

source_name: breast cancer, sample MDACC-509

value: MDACC

value: pCR

value: Basal

value: breast cancer tumor


title: 437

source_name: breast cancer, sample MDACC-437

value: IIB

value: RCB-III


title: 440

source_name: breast cancer, sample MDACC-440

value: N

value: RCB-II

value: Rx Sensitive

value: LumB


title: 342

source_name: breast cancer, sample MDACC-342

value: IIA

value: Taxotere

value: SET-Low

value: Low

value: LumA


title: 480

source_name: breast cancer, sample MDACC-480

value: P

value: RD

value: Rx Insensitive

value: Normal

value: RCB-II/III


title: 364

source_name: breast cancer, sample MDACC-364

value: MDACC

value: breast cancer tumor


title: 324

source_name: breast cancer, sample MDACC-324

value: IIB

value: pCR

value: High

value: Basal


title: 327

source_name: breast cancer, sample MDACC-327

value: N

value: IIIA


title: 336

source_name: breast cancer, sample MDACC-336

value: Taxotere


title: 348

source_name: breast cancer, sample MDACC-348

value: RCB-II

value: SET-Low

value: Rx Sensitive


title: 544

source_name: breast cancer, sample MDACC-544

value: IIA

value: P


title: 337

source_name: breast cancer, sample MDACC-337

value: RD

value: RCB-III

value: Rx Insensitive

value: Low

value: LumA


title: 305

source_name: breast cancer, sample MDACC-305

value: MDACC

value: IIB

value: breast cancer tumor


title: 161

source_name: breast cancer, sample USO-161

value: USO

value: Normal

value: RCB-II/III


title: 268

source_name: breast cancer, sample MDACC-268

value: N

value: Taxotere

value: SET-Int


title: 320

source_name: breast cancer, sample MDACC-320

value: SET-Low

value: High


title: 155

source_name: breast cancer, sample USO-155

value: P

value: Rx Sensitive


title: 154

source_name: breast cancer, sample USO-154

value: IIA

value: pCR

value: Basal


title: 293

source_name: breast cancer, sample MDACC-293

value: RD

value: RCB-III

value: Rx Insensitive


title: 159

source_name: breast cancer, sample USO-159

value: IIB

value: Low

value: LumA

value: breast cancer tumor


title: 223

source_name: breast cancer, sample MDACC-223

value: MDACC

value: N

value: RCB-II

value: RCB-II/III


title: 249

source_name: breast cancer, sample MDACC-249

value: Taxotere

value: SET-Low

value: High


title: 225

source_name: breast cancer, sample MDACC-225

value: P

value: IIA


title: 148

source_name: breast cancer, sample USO-148

value: USO


title: 272

source_name: breast cancer, sample MDACC-272

value: RD

value: Basal

value: pCR


title: 290

source_name: breast cancer, sample MDACC-290

value: Rx Insensitive


title: 150

source_name: breast cancer, sample USO-150

value: IIB

value: Rx Sensitive


title: 113

source_name: breast cancer, sample USO-113

value: breast cancer tumor


title: 124

source_name: breast cancer, sample USO-124

value: LumB


title: 118

source_name: breast cancer, sample USO-118

value: N


title: 130

source_name: breast cancer, sample USO-130

value: LumA


title: 145

source_name: breast cancer, sample USO-145

value: IIIC


title: 149

source_name: breast cancer, sample USO-149

value: IIIA

value: Taxotere


title: 110

source_name: breast cancer, sample USO-110

value: SET-Low

value: High

value: RCB-II/III


title: 133

source_name: breast cancer, sample USO-133

value: USO

value: P


title: 112

source_name: breast cancer, sample USO-112

value: RD


title: 111

source_name: breast cancer, sample USO-111

value: pCR


title: 104

source_name: breast cancer, sample USO-104

value: Rx Insensitive

value: Basal


title: 97

source_name: breast cancer, sample USO-97


title: 125

source_name: breast cancer, sample USO-125

value: IIA


title: 103

source_name: breast cancer, sample USO-103

value: IIB

value: breast cancer tumor


title: 100

source_name: breast cancer, sample USO-100

value: N

value: LumB


title: 80

source_name: breast cancer, sample USO-80

value: LumA


title: 96

source_name: breast cancer, sample USO-96


title: 77

source_name: breast cancer, sample USO-77

value: IIIA


title: 94

source_name: breast cancer, sample USO-94

value: Taxotere

value: Low


title: 106

source_name: breast cancer, sample USO-106

value: SET-Low

value: High


title: 67

source_name: breast cancer, sample USO-67

value: USO

value: RCB-II/III


title: 76

source_name: breast cancer, sample USO-76

value: P

value: RD


title: 101

source_name: breast cancer, sample USO-101

value: Rx Insensitive

value: Normal

value: pCR


title: 88

source_name: breast cancer, sample USO-88

value: IIB

value: Basal


title: 70

source_name: breast cancer, sample USO-70

value: N

value: breast cancer tumor


title: 86

source_name: breast cancer, sample USO-86


title: 68

source_name: breast cancer, sample USO-68

value: Rx Sensitive


title: 95

source_name: breast cancer, sample USO-95

value: IIIC


title: 85

source_name: breast cancer, sample USO-85

value: IIIA

value: Taxotere

value: LumB


title: 87

source_name: breast cancer, sample USO-87

value: SET-Low

value: High


title: 31

source_name: breast cancer, sample USO-31

value: USO

value: RCB-II/III


title: 32

source_name: breast cancer, sample USO-32

value: P

value: RD


title: 36

source_name: breast cancer, sample USO-36

value: Rx Insensitive


title: 48

source_name: breast cancer, sample USO-48

value: Low

value: LumA


title: 35

source_name: breast cancer, sample USO-35

value: IIB

value: SET-High


title: 52

source_name: breast cancer, sample USO-52

value: N

value: Basal

value: pCR

value: breast cancer tumor


title: 46

source_name: breast cancer, sample USO-46

value: IIIA

value: Taxotere


title: 51

source_name: breast cancer, sample USO-51

value: IIA

value: SET-Low


title: 30

source_name: breast cancer, sample USO-30

value: USO

value: High


title: 45

source_name: breast cancer, sample USO-45

value: Rx Sensitive


title: 23

source_name: breast cancer, sample USO-23

value: RD


title: 24

source_name: breast cancer, sample USO-24

value: P

value: Rx Insensitive

value: RCB-II/III


title: 18

source_name: breast cancer, sample USO-18

value: IIIC

value: LumB


title: 20

source_name: breast cancer, sample USO-20

value: N


title: PERU09

source_name: breast cancer, sample MDACC-PERU09

value: MDACC

tag: er_status_ihc_esr1_for indeterminate

value: IIIB

value: RCB-III

value: LumA


title: M795

source_name: breast cancer, sample MDACC-M795

value: Low


title: PERU14_16

source_name: breast cancer, sample MDACC-PERU14_16

value: pCR


title: M806

source_name: breast cancer, sample MDACC-M806

value: SET-Low


title: M805

source_name: breast cancer, sample MDACC-M805

value: IIB

value: Basal


title: 13

source_name: breast cancer, sample USO-13

value: USO

value: IIA

value: Taxotere

value: High

value: breast cancer tumor


title: 1

source_name: breast cancer, sample USO-1

value: P

value: RD

value: Rx Insensitive

value: RCB-II/III


title: PERU12_14

source_name: breast cancer, sample MDACC-PERU12_14

value: MDACC

value: N

value: IIIA

value: LumB


title: PERU01

source_name: breast cancer, sample MDACC-PERU01

value: IIIB

value: RCB-II

value: Low

value: LumA


title: 5

source_name: breast cancer, sample USO-5

value: USO

value: IIB

value: pCR

value: SET-Low

value: Basal


title: M810

source_name: breast cancer, sample MDACC-M810

value: P

value: RCB-III


title: M782

source_name: breast cancer, sample MDACC-M782

value: RD

value: Rx Insensitive


title: M794

source_name: breast cancer, sample MDACC-M794

value: MDACC

value: IIA

value: High


title: M774

source_name: breast cancer, sample MDACC-M774

value: N

value: RCB-II/III


title: PERU07

source_name: breast cancer, sample MDACC-PERU07

value: IIIB

value: RCB-II

value: LumB


title: M802

source_name: breast cancer, sample MDACC-M802

value: IIIA

value: Rx Sensitive


title: M771

source_name: breast cancer, sample MDACC-M771

value: Low

value: pCR


title: 12

source_name: breast cancer, sample USO-12

value: USO

value: IIB

value: Taxotere

value: SET-Low

value: breast cancer tumor


title: M792

source_name: breast cancer, sample MDACC-M792

value: MDACC

value: Rx Insensitive

value: Basal


title: M784

source_name: breast cancer, sample MDACC-M784

value: P

value: N

value: RD

value: High


title: M779

source_name: breast cancer, sample MDACC-M779

value: RCB-III

value: RCB-II/III


title: PERU11

source_name: breast cancer, sample MDACC-PERU11

value: IIIB

value: RCB-II


title: M753

source_name: breast cancer, sample MDACC-M753

value: LumB


title: M744

source_name: breast cancer, sample MDACC-M744

value: Low


title: M781

source_name: breast cancer, sample MDACC-M781

value: IIB

value: SET-Int

value: Rx Sensitive

value: LumA


title: M732

source_name: breast cancer, sample MDACC-M732

value: MDACC

value: IIIA

value: SET-Low

value: pCR


title: M739

source_name: breast cancer, sample MDACC-M739

value: N

value: Basal


title: M750

source_name: breast cancer, sample MDACC-M750

value: P

value: Rx Insensitive

value: High


title: M765

source_name: breast cancer, sample MDACC-M765

value: IIIB

value: RD

value: RCB-III

value: RCB-II/III


title: M723

source_name: breast cancer, sample MDACC-M723

value: IIB

value: RCB-II

value: Low


title: M766

source_name: breast cancer, sample MDACC-M766

value: IIA


title: M735

source_name: breast cancer, sample MDACC-M735

value: MDACC

value: Rx Sensitive


title: M763

source_name: breast cancer, sample MDACC-M763

value: IIIA

value: SET-Low


title: M768

source_name: breast cancer, sample MDACC-M768

value: N

value: pCR


title: M734

source_name: breast cancer, sample MDACC-M734

value: P

value: LumA


title: M767

source_name: breast cancer, sample MDACC-M767

value: SET-Int


title: M746

source_name: breast cancer, sample MDACC-M746


title: M791

source_name: breast cancer, sample MDACC-M791

value: IIIB

value: Rx Insensitive

value: High

value: Basal


title: M729

source_name: breast cancer, sample MDACC-M729

value: IIB

value: RD

value: RCB-III

value: RCB-II/III


title: M757

source_name: breast cancer, sample MDACC-M757

value: MDACC


title: M751

source_name: breast cancer, sample MDACC-M751


title: M758

source_name: breast cancer, sample MDACC-M758


title: M728

source_name: breast cancer, sample MDACC-M728

value: LumB


title: M725

source_name: breast cancer, sample MDACC-M725

value: RCB-II


title: M710

source_name: breast cancer, sample MDACC-M710

value: SET-Low


title: M722

source_name: breast cancer, sample MDACC-M722

value: N

value: IIIA


title: M717

source_name: breast cancer, sample MDACC-M717

value: P

value: IIA

value: Rx Sensitive

value: Low


title: M718

source_name: breast cancer, sample MDACC-M718

value: Rx Insensitive

value: pCR


title: M714

source_name: breast cancer, sample MDACC-M714

value: Normal


title: M709

source_name: breast cancer, sample MDACC-M709

value: IIIB

value: High

value: Basal


title: M693

source_name: breast cancer, sample MDACC-M693

value: RD

value: LumA

value: RCB-II/III


title: M679

source_name: breast cancer, sample MDACC-M679

value: MDACC

value: RCB-II


title: M670

source_name: breast cancer, sample MDACC-M670

value: N

value: IIB

value: SET-Low


title: M668

source_name: breast cancer, sample MDACC-M668

value: P

value: IIIA


title: M681

source_name: breast cancer, sample MDACC-M681


title: M685

source_name: breast cancer, sample MDACC-M685

value: IIA

value: RCB-III

value: Low


title: M692

source_name: breast cancer, sample MDACC-M692

value: pCR

value: Rx Sensitive


title: M696

source_name: breast cancer, sample MDACC-M696

value: Rx Insensitive

value: High


title: M691

source_name: breast cancer, sample MDACC-M691

value: LumB

value: RD


title: M695

source_name: breast cancer, sample MDACC-M695

value: RCB-II/III


title: M677

source_name: breast cancer, sample MDACC-M677

value: MDACC

value: Basal


title: M682

source_name: breast cancer, sample MDACC-M682

value: N

value: RCB-II

value: LumA


title: M659

source_name: breast cancer, sample MDACC-M659

value: IIB

value: SET-Low


title: M706

source_name: breast cancer, sample MDACC-M706

value: P

value: IIIB


title: M669

source_name: breast cancer, sample MDACC-M669

value: SET-Int

value: Low


title: M666

source_name: breast cancer, sample MDACC-M666

value: IIA

value: Rx Sensitive


title: M673

source_name: breast cancer, sample MDACC-M673

value: Rx Insensitive

value: Normal

value: pCR


title: M661

source_name: breast cancer, sample MDACC-M661

value: High


title: M690

source_name: breast cancer, sample MDACC-M690

value: MDACC

value: RD

value: RCB-II/III


title: M683

source_name: breast cancer, sample MDACC-M683

value: N

value: RCB-II

value: LumB


title: M657

source_name: breast cancer, sample MDACC-M657

value: I

value: SET-Low

value: Basal


title: M665

source_name: breast cancer, sample MDACC-M665

value: IIB


title: M658

source_name: breast cancer, sample MDACC-M658

value: IIIB


title: M671

source_name: breast cancer, sample MDACC-M671

value: P

value: IIA


title: M675

source_name: breast cancer, sample MDACC-M675

value: RCB-III

value: Rx Insensitive


title: M662

source_name: breast cancer, sample MDACC-M662

value: Low

value: LumA


title: M651

source_name: breast cancer, sample MDACC-M651

value: MDACC

value: pCR

value: Rx Sensitive

value: High


title: M652

source_name: breast cancer, sample MDACC-M652

value: N

value: RD

value: RCB-II

value: RCB-II/III


title: M783

source_name: breast cancer, sample MDACC-M783

value: IIIA

value: SET-Low

value: Basal


title: M643

source_name: breast cancer, sample MDACC-M643

value: P


title: M647

source_name: breast cancer, sample MDACC-M647


title: M636

source_name: breast cancer, sample MDACC-M636

value: IIA


title: M642

source_name: breast cancer, sample MDACC-M642

value: IIIB

value: RCB-III


title: M581

source_name: breast cancer, sample MDACC-M581

value: Rx Insensitive


title: M612

source_name: breast cancer, sample MDACC-M612


title: M608

source_name: breast cancer, sample MDACC-M608

value: IIIC


title: M601

source_name: breast cancer, sample MDACC-M601

value: MDACC

value: IIB

value: Low

value: LumA


title: M578

source_name: breast cancer, sample MDACC-M578

value: N

value: High

value: LumB


title: M617

source_name: breast cancer, sample MDACC-M617

value: RD

value: RCB-II

value: pCR

value: RCB-II/III


title: M624

source_name: breast cancer, sample MDACC-M624

value: SET-Low

value: Normal


title: M639

source_name: breast cancer, sample MDACC-M639

value: Basal


title: M565

source_name: breast cancer, sample MDACC-M565

value: P

value: IIIA


title: M625

source_name: breast cancer, sample MDACC-M625

value: IIA

value: Rx Sensitive


title: M577

source_name: breast cancer, sample MDACC-M577

value: MDACC

value: IIB

value: Rx Insensitive


title: M564

source_name: breast cancer, sample MDACC-M564

value: N

value: IIIB

value: RCB-III


title: M583

source_name: breast cancer, sample MDACC-M583

value: RD

value: Low


title: M619

source_name: breast cancer, sample MDACC-M619

value: High

value: pCR


title: M569

source_name: breast cancer, sample MDACC-M569

value: SET-Low

value: LumA

value: RCB-II/III


title: M557

source_name: breast cancer, sample MDACC-M557

value: Basal


title: M559

source_name: breast cancer, sample MDACC-M559

value: P

value: RCB-II


title: M571

source_name: breast cancer, sample MDACC-M571

value: Rx Sensitive


title: M635

source_name: breast cancer, sample MDACC-M635

value: MDACC

value: IIIC


title: M603

source_name: breast cancer, sample MDACC-M603

value: Rx Insensitive


title: M611

source_name: breast cancer, sample MDACC-M611

value: N


title: M599

source_name: breast cancer, sample MDACC-M599

value: IIA

value: SET-Int

value: Normal


title: M558

source_name: breast cancer, sample MDACC-M558

value: IIIB

value: RD

value: RCB-III


title: M556

source_name: breast cancer, sample MDACC-M556

value: SET-Low

value: Low


title: M566

source_name: breast cancer, sample MDACC-M566

value: LumA

value: RCB-II/III


title: M610

source_name: breast cancer, sample MDACC-M610

value: P

value: IIIA


title: M607

source_name: breast cancer, sample MDACC-M607

value: RCB-II


title: M580

source_name: breast cancer, sample MDACC-M580

value: MDACC

value: pCR

value: Rx Sensitive

value: High

value: Basal


title: M534

source_name: breast cancer, sample MDACC-M534

value: N

value: IIIC

value: SET-Int


title: M531

source_name: breast cancer, sample MDACC-M531

value: IIIB

value: RD

value: Rx Insensitive

value: Normal


title: M524

source_name: breast cancer, sample MDACC-M524

value: IIA

value: SET-Low


title: M549

source_name: breast cancer, sample MDACC-M549

value: P

value: IIB

value: RCB-III

value: Low

value: LumA

value: RCB-II/III


title: M545

source_name: breast cancer, sample MDACC-M545

value: MDACC

value: RCB-II

value: High


title: M502

source_name: breast cancer, sample MDACC-M502

value: N


title: M525

source_name: breast cancer, sample MDACC-M525

value: SET-Int

value: Rx Sensitive


title: M506

source_name: breast cancer, sample MDACC-M506

value: RD

value: LumB


title: M523

source_name: breast cancer, sample MDACC-M523

value: SET-High


title: M513

source_name: breast cancer, sample MDACC-M513

value: pCR

value: Basal


title: M507

source_name: breast cancer, sample MDACC-M507

value: P

value: IIA

value: SET-Low

value: Rx Insensitive


title: M433

source_name: breast cancer, sample MDACC-M433

value: Low

value: LumA


title: M442

source_name: breast cancer, sample MDACC-M442

value: MDACC

value: IIIA


title: M411

source_name: breast cancer, sample MDACC-M411

value: IIB

value: RCB-III

value: High


title: M434

source_name: breast cancer, sample MDACC-M434

value: N

value: RCB-II/III


title: M421

source_name: breast cancer, sample MDACC-M421

value: RD


title: M485

source_name: breast cancer, sample MDACC-M485

value: IIIB

value: Rx Sensitive


title: M463

source_name: breast cancer, sample MDACC-M463

value: RCB-II


title: M430

source_name: breast cancer, sample MDACC-M430

value: Basal

value: pCR


title: M447

source_name: breast cancer, sample MDACC-M447

value: P

value: IIA

value: SET-Low

value: LumB


title: M425

source_name: breast cancer, sample MDACC-M425

value: MDACC

value: Rx Insensitive


title: M486

source_name: breast cancer, sample MDACC-M486

value: Low

value: LumA


title: M431

source_name: breast cancer, sample MDACC-M431

value: IIB

value: SET-High


title: M417

source_name: breast cancer, sample MDACC-M417

value: N

value: RCB-II/III


title: M399

source_name: breast cancer, sample MDACC-M399

value: RD


title: M503

source_name: breast cancer, sample MDACC-M503

value: I

value: High


title: M402

source_name: breast cancer, sample MDACC-M402

value: IIIB

value: Basal


title: M497

source_name: breast cancer, sample MDACC-M497

value: P

value: IIIC

value: Rx Sensitive


title: M396

source_name: breast cancer, sample MDACC-M396

value: IIIA

value: RCB-III

value: SET-Low


title: M384

source_name: breast cancer, sample MDACC-M384

value: MDACC

value: RCB-II

value: SET-Int

value: Low


title: M469

source_name: breast cancer, sample MDACC-M469

value: N

value: Rx Insensitive

value: LumA


title: M373

source_name: breast cancer, sample MDACC-M373

value: IIA

value: pCR


title: M375

source_name: breast cancer, sample MDACC-M375

value: IIB

value: RD

value: Normal

value: RCB-II/III


title: M367

source_name: breast cancer, sample MDACC-M367

value: IIIB

value: Rx Sensitive

value: High


title: M365

source_name: breast cancer, sample MDACC-M365

value: P

value: SET-Low


title: M363

source_name: breast cancer, sample MDACC-M363

value: MDACC

value: RCB-II


title: M360

source_name: breast cancer, sample MDACC-M360

value: Basal


title: M423

source_name: breast cancer, sample MDACC-M423

value: N

value: IIIC


title: M386

source_name: breast cancer, sample MDACC-M386

value: LumB


title: M357

source_name: breast cancer, sample MDACC-M357

value: IIA

value: RCB-III

value: SET-High

value: LumA


title: M356

source_name: breast cancer, sample MDACC-M356

value: IIB

value: RD

value: SET-Int

value: Low

value: Normal


title: M355

source_name: breast cancer, sample MDACC-M355

value: P

value: IIIA

value: Rx Insensitive

value: RCB-II/III


title: M315

source_name: breast cancer, sample MDACC-M315

value: MDACC

value: SET-Low


title: M319

source_name: breast cancer, sample MDACC-M319

value: N

value: Rx Sensitive


title: M340

source_name: breast cancer, sample MDACC-M340

value: IIIB

value: RCB-II


title: M345

source_name: breast cancer, sample MDACC-M345

value: RCB-III

value: High

value: Basal

value: pCR


title: M353

source_name: breast cancer, sample MDACC-M353

value: LumB

value: RD


title: M334

source_name: breast cancer, sample MDACC-M334

value: IIA


title: M343

source_name: breast cancer, sample MDACC-M343

value: P

value: IIIC

value: SET-Int

value: Low

value: LumA


title: M339

source_name: breast cancer, sample MDACC-M339

value: MDACC

value: IIB

value: SET-Low

value: Rx Insensitive

value: RCB-II/III


title: M341

source_name: breast cancer, sample MDACC-M341

value: N

value: RCB-III


title: M323

source_name: breast cancer, sample MDACC-M323

value: SET-High

value: Rx Sensitive


title: M332

source_name: breast cancer, sample MDACC-M332

value: IIIA

value: RCB-II

value: High

value: Basal

value: pCR


title: M301

source_name: breast cancer, sample MDACC-M301


title: M333

source_name: breast cancer, sample MDACC-M333

value: P

value: RD


title: M283

source_name: breast cancer, sample MDACC-M283

value: IIIB

value: Low

value: LumA


title: M295

source_name: breast cancer, sample MDACC-M295

value: MDACC

value: IIB

value: SET-Low


title: M281

source_name: breast cancer, sample MDACC-M281

value: N

value: IIA

value: Rx Insensitive

value: RCB-II/III


title: M310

source_name: breast cancer, sample MDACC-M310

value: Rx Sensitive


title: M297

source_name: breast cancer, sample MDACC-M297

value: RCB-III


title: M270

source_name: breast cancer, sample MDACC-M270

value: High

value: LumB


title: M304

source_name: breast cancer, sample MDACC-M304


title: M282

source_name: breast cancer, sample MDACC-M282

value: RCB-II


title: M261

source_name: breast cancer, sample MDACC-M261

value: P

value: SET-Int


title: M260

source_name: breast cancer, sample MDACC-M260

value: IIIA

value: RD


title: M263

source_name: breast cancer, sample MDACC-M263

value: Low

value: Normal


title: M280

source_name: breast cancer, sample MDACC-M280

value: MDACC

value: IIIB

value: LumA


title: M266

source_name: breast cancer, sample MDACC-M266

value: N

value: SET-Low


title: M259

source_name: breast cancer, sample MDACC-M259

value: IIA


title: M255

source_name: breast cancer, sample MDACC-M255

value: Rx Sensitive

value: RCB-II/III


title: M246

source_name: breast cancer, sample MDACC-M246

value: RCB-III

value: Rx Insensitive


title: M220

source_name: breast cancer, sample MDACC-M220

value: High

value: Basal


title: M228

source_name: breast cancer, sample MDACC-M228

value: P

value: RCB-II


title: M236

source_name: breast cancer, sample MDACC-M236

value: IIB

value: RD

value: LumB


title: M229

source_name: breast cancer, sample MDACC-M229

value: MDACC

value: IIIA

value: pCR


title: M233

source_name: breast cancer, sample MDACC-M233

value: N

value: IIIB


title: M231

source_name: breast cancer, sample MDACC-M231

value: IIA

value: SET-Low

value: Low

value: LumA


title: M216

source_name: breast cancer, sample MDACC-M216

value: Rx Sensitive


title: M219

source_name: breast cancer, sample MDACC-M219

value: RCB-III

value: Rx Insensitive

value: High

value: RCB-II/III


title: M234

source_name: breast cancer, sample MDACC-M234

value: P

value: IIB

value: Normal


title: M214

source_name: breast cancer, sample MDACC-M214

value: MDACC

value: RD


title: M226

source_name: breast cancer, sample MDACC-M226


title: M205

source_name: breast cancer, sample MDACC-M205

value: pCR

value: Basal


title: M217

source_name: breast cancer, sample MDACC-M217

value: N

value: RCB-II

value: SET-High


title: M189

source_name: breast cancer, sample MDACC-M189

value: SET-Low

value: LumB


title: M195

source_name: breast cancer, sample MDACC-M195

value: IIA

value: SET-Int

value: Rx Sensitive

value: Low

value: LumA


title: M206

source_name: breast cancer, sample MDACC-M206

value: High


title: M215

source_name: breast cancer, sample MDACC-M215

value: IIB


title: M201

source_name: breast cancer, sample MDACC-M201

value: P

value: Rx Insensitive

value: RCB-II/III


title: M227

source_name: breast cancer, sample MDACC-M227

value: MDACC

value: RD


title: M211

source_name: breast cancer, sample MDACC-M211

value: N

value: IIIA

value: pCR

value: Basal


title: M199

source_name: breast cancer, sample MDACC-M199

value: IIIC

value: SET-Low


title: M196

source_name: breast cancer, sample MDACC-M196

value: RCB-III


title: M188

source_name: breast cancer, sample MDACC-M188

value: LumB


title: M177

source_name: breast cancer, sample MDACC-M177

value: Rx Sensitive


title: M180

source_name: breast cancer, sample MDACC-M180

value: SET-High


title: M181

source_name: breast cancer, sample MDACC-M181

value: RCB-II

value: Low

value: LumA


title: M153

source_name: breast cancer, sample MDACC-M153

value: P

value: IIA

value: High


title: M156

source_name: breast cancer, sample MDACC-M156

value: MDACC

value: RD

value: Rx Insensitive

value: RCB-II/III


title: M154

source_name: breast cancer, sample MDACC-M154

value: N

value: IIIB

value: Basal

value: pCR


title: M130

source_name: breast cancer, sample MDACC-M130

value: IIB

value: SET-Low


title: M133

source_name: breast cancer, sample MDACC-M133

value: Rx Sensitive


title: M129

source_name: breast cancer, sample MDACC-M129

value: RCB-II

value: SET-High

value: LumB


title: M165

source_name: breast cancer, sample MDACC-M165

value: P


title: M157

source_name: breast cancer, sample MDACC-M157

value: IIA

value: SET-Int

value: LumA


title: M182

source_name: breast cancer, sample MDACC-M182

value: MDACC

value: I

value: RD

value: Low


title: M128

source_name: breast cancer, sample MDACC-M128

value: N

value: Rx Insensitive

value: RCB-II/III


title: M123

source_name: breast cancer, sample MDACC-M123

value: IIIB

value: pCR

value: High


title: M139

source_name: breast cancer, sample MDACC-M139

value: RCB-II

value: SET-Low

value: Rx Sensitive


title: M120

source_name: breast cancer, sample MDACC-M120

value: P

value: Basal


title: M146

source_name: breast cancer, sample MDACC-M146

value: Normal


title: M158

source_name: breast cancer, sample MDACC-M158

value: IIIA

value: LumA


title: M106

source_name: breast cancer, sample MDACC-M106

value: MDACC

value: IIA

value: breast cancer tumor


title: M155

source_name: breast cancer, sample MDACC-M155

value: N

value: RD

value: LumB


title: M111

source_name: breast cancer, sample MDACC-M111

value: Rx Insensitive


title: M113

source_name: breast cancer, sample MDACC-M113


title: M117

source_name: breast cancer, sample MDACC-M117

value: IIB

value: Low

value: RCB-II/III


title: M107

source_name: breast cancer, sample MDACC-M107

value: RCB-II

value: SET-Low


title: M136

source_name: breast cancer, sample MDACC-M136

value: P

value: I

value: pCR

value: High


title: 1232

source_name: breast cancer, sample ISPY-1232

value: ISPY

value: IIIA

value: SET-Int

value: Rx Sensitive

value: LumA


title: 1231

source_name: breast cancer, sample ISPY-1231

value: N

value: RD

value: Normal

value: breast cancer tumor


title: 1227

source_name: breast cancer, sample ISPY-1227

value: IIB

value: Rx Insensitive

value: Basal


title: 1236

source_name: breast cancer, sample ISPY-1236

value: RCB-III

value: SET-Low

value: RCB-II/III


title: 1225

source_name: breast cancer, sample ISPY-1225

value: P

value: IIA

value: RCB-II

value: SET-High

value: Low


title: M121

source_name: breast cancer, sample MDACC-M121

value: MDACC

value: I

value: Rx Sensitive

value: High

value: pCR


title: 1219

source_name: breast cancer, sample ISPY-1219

value: ISPY

value: RD

value: N

value: LumA

value: breast cancer tumor


title: 1220

source_name: breast cancer, sample ISPY-1220

value: IIB

value: SET-Low

value: Rx Insensitive

value: Basal


title: 1209

source_name: breast cancer, sample ISPY-1209

value: P

value: IIA

value: RCB-II

value: Normal

value: RCB-II/III


title: 1223

source_name: breast cancer, sample ISPY-1223

value: SET-Int

value: Rx Sensitive

value: Low


title: 1203

source_name: breast cancer, sample ISPY-1203

value: ISPY

value: IIIA


title: 1218

source_name: breast cancer, sample ISPY-1218

value: N

value: RD

value: High

value: pCR


title: 1197

source_name: breast cancer, sample ISPY-1197

value: IIB

value: SET-Low

value: breast cancer tumor


title: 1210

source_name: breast cancer, sample ISPY-1210

value: P

value: SET-High


title: 1217

source_name: breast cancer, sample ISPY-1217

value: IIA

value: Rx Insensitive

value: LumA


title: 1177

source_name: breast cancer, sample ISPY-1177

value: Basal


title: 1200

source_name: breast cancer, sample ISPY-1200

value: I

value: RCB-III

value: Rx Sensitive

value: RCB-II/III


title: 1180

source_name: breast cancer, sample ISPY-1180

value: ISPY

value: N

value: IIIB

value: RCB-II

value: SET-Int


title: 1216

source_name: breast cancer, sample ISPY-1216

value: IIIA

value: pCR

value: SET-Low

value: Low

value: Normal

value: RD


title: 1199

source_name: breast cancer, sample ISPY-1199

value: Rx Insensitive

value: High

value: breast cancer tumor


title: 1188

source_name: breast cancer, sample ISPY-1188

value: IIB

value: Basal


title: 1173

source_name: breast cancer, sample ISPY-1173

value: I

value: RCB-II/III


title: 1208

source_name: breast cancer, sample ISPY-1208

value: ISPY

value: N

value: Rx Sensitive


title: 1193

source_name: breast cancer, sample ISPY-1193

value: P

value: IIA

value: RCB-III

value: LumA


title: 1191

source_name: breast cancer, sample ISPY-1191

value: RCB-II

value: SET-Low


title: 1172

source_name: breast cancer, sample ISPY-1172

value: RD

value: pCR


title: 1226

source_name: breast cancer, sample ISPY-1226

value: IIIA

value: Rx Insensitive

value: High

value: LumB


title: 1170

source_name: breast cancer, sample ISPY-1170

value: SET-High

value: Low

value: breast cancer tumor


title: 1175

source_name: breast cancer, sample ISPY-1175

value: ISPY

value: N

value: RCB-II/III


title: 1164

source_name: breast cancer, sample ISPY-1164

value: P

value: I

value: SET-Int

value: Rx Sensitive


title: 1205

source_name: breast cancer, sample ISPY-1205


title: 1163

source_name: breast cancer, sample ISPY-1163

value: IIA

value: SET-Low

value: Basal


title: 1169

source_name: breast cancer, sample ISPY-1169

value: IIIA

value: RD

value: RCB-III

value: pCR


title: 1160

source_name: breast cancer, sample ISPY-1160

value: Rx Insensitive

value: High


title: 1158

source_name: breast cancer, sample ISPY-1158

value: RCB-II

value: LumA

value: breast cancer tumor


title: 1165

source_name: breast cancer, sample ISPY-1165

value: ISPY

value: N

value: RCB-II/III


title: 1145

source_name: breast cancer, sample ISPY-1145

value: P


title: 1150

source_name: breast cancer, sample ISPY-1150

value: SET-Int

value: Rx Sensitive